Cutler Group’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-217,100
| Closed | -$6.54M | – | 5039 |
|
|
2019
Q4 | $6.54M | Buy |
217,100
+100,700
| +87% | +$6.72M | 0.4% | 38 |
|
|
2019
Q3 | $1.62M | Sell |
116,400
-10,800
| -8% | -$431K | 0.15% | 108 |
|
|
2019
Q2 | $1.03M | Buy |
127,200
+19,900
| +19% | +$650K | 0.1% | 186 |
|
|
2019
Q1 | $698K | Buy |
107,300
+92,500
| +625% | +$2.18M | 0.07% | 248 |
|
|
2018
Q4 | $39K | Buy |
14,800
+8,300
| +128% | +$193K | ﹤0.01% | 1646 |
|
|
2018
Q3 | $8K | Sell |
6,500
-15,000
| -70% | -$565K | ﹤0.01% | 2823 |
|
|
2018
Q2 | $54K | Buy |
21,500
+11,000
| +105% | +$357K | ﹤0.01% | 1564 |
|
|
2018
Q1 | $22K | Sell |
10,500
-29,100
| -73% | -$909K | ﹤0.01% | 2239 |
|
|
2017
Q4 | $16K | Sell |
39,600
-56,500
| -59% | -$1.74M | ﹤0.01% | 2780 |
|
|
2017
Q3 | $112K | Sell |
96,100
-9,300
| -9% | -$343K | ﹤0.01% | 1584 |
|
|
2017
Q2 | $147K | Sell |
105,400
-27,900
| -21% | -$1.24M | 0.01% | 1538 |
|
|
2017
Q1 | $623K | Buy |
133,300
+118,900
| +826% | +$5.42M | 0.03% | 558 |
|
|
2016
Q4 | $24K | Sell |
14,400
-218,400
| -94% | -$7.75M | ﹤0.01% | 3299 |
|
|
2016
Q3 | $402K | Buy |
232,800
+219,600
| +1,664% | +$8.28M | 0.02% | 724 |
|
|
2016
Q2 | $19K | Sell |
13,200
-8,100
| -38% | -$286K | ﹤0.01% | 3444 |
|
|
2016
Q1 | $28K | Buy |
21,300
+5,300
| +33% | +$173K | ﹤0.01% | 2945 |
|
|
2015
Q4 | $60K | Buy |
+16,000
| New | +$605K | ﹤0.01% | 2275 |
|
Other funds holding MDCO
Cutler Group's MDCO Position: Q1 2020 in Review
Cutler Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 49,500 shares — an estimated $4.2M sold.
Cutler Group first reported a position in MDCO in Q4 2015 and held it in 17 quarters. The position peaked at $4.42M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Cutler Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Cutler Group sold 49,500 Medicines Co shares in Q1 2020, an estimated $4.2M.
- Cutler Group first reported a position in Medicines Co in Q4 2015 and held it in 17 quarters.
- Cutler Group's Medicines Co position peaked at $4.42M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.